Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-10,000
Closed -$668K 6900
2019
Q2
$668K Buy
+10,000
New +$761K ﹤0.01% 4077
2018
Q1
Sell
-1,000
Closed -$119K 7180
2017
Q4
$119K Buy
+1,000
New +$110K ﹤0.01% 5106
2017
Q2
Sell
-60,000
Closed -$4.65M 6769
2017
Q1
$4.65M Sell
60,000
-5,000
-8% -$346K 0.01% 1373
2016
Q4
$4.37M Buy
+65,000
New +$4.01M ﹤0.01% 1483

Other funds holding INGN

Barclays's INGN Position: Q1 2026 in Review

Barclays reduced its Inogen (INGN) stake by 47% in Q1 2026, selling an estimated $240K and leaving 43,087 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3531.

Barclays first reported a position in INGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.79M in Q4 2015. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • Barclays held 43,087 shares of Inogen worth $266K as of Q1 2026.
  • Barclays sold 38,893 Inogen shares in Q1 2026, an estimated $240K.
  • Inogen made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3531 holding.
  • Barclays first reported a position in Inogen in Q1 2014 and has held it in 49 quarters since.
  • Barclays's Inogen position peaked at $3.79M in Q4 2015.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.